Rate of and Risk Factors for Loss to Follow Up in HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Owing to antiretroviral therapy (ART), acquired immune deficiency syndrome (AIDS)-related mortality has significantly decreased. Retaining in care is an essential step for human immunodeficiency virus (HIV) care cascade. This study investigated the incidence of and risk factors for loss to follow-up (LTFU) in Korean people living with HIV (PLWH). Materials and Methods: Data from the Korea HIV/AIDS cohort study (including prospective interval cohort and retrospective clinical cohort) were analyzed. LTFU was defined as not visiting the clinic for more than 1 year. Risk factors for LTFU were identified using the Cox regression hazard model. Results: The study enrolled 3,172 adult HIV patients (median age, 36 years; male 92.97%). The median CD4 T cell count at enrollment was 234 cells/mm3 (interquartile range [IQR]: 85 - 373) and the median viral load at enrollment was 56,100 copies/mL (IQR: 15,000 - 203,992). The total follow-up duration was 16,487 person-years, and the overall incidence rate of LTFU was 85/1,000 person-years.In the multivariable Cox regression model, subjects on ART were less likely to have LTFU than subjects not on ART (hazard ratio [HR] = 0.253, 95% confidence interval [CI]: 0.220 - 0.291, P <0.0001). Among PLWH on ART, female sex (HR = 0.752, 95% CI: 0.582 - 0.971, P = 0.0291) and older age (>50: HR = 0.732, 95% CI: 0.602 - 0.890; 41 - 50: HR = 0.634, 95% CI: 0.530 - 0.750; 31 - 40: HR = 0.724, 95% CI: 0.618 - 0.847; ≤30: reference, P <0.0001) were associated with high rate of retention in care. The viral load at ART initiation ≥1,000,001 (HR = 1.545, 95% CI: 1.126 - 2.121, ≤10,000: reference) was associated with a higher rate of LTFU. Conclusion: Young and male PLWH may have a higher rate of LTFU, and an increased rate of LTFU may induce virologic failure.
Abstract
Background: Owing to antiretroviral therapy (ART), acquired immune deficiency syndrome (AIDS)-related mortality has significantly decreased. Retaining in care is an essential step for human immunodeficiency virus (HIV) care cascade. This study investigated the incidence of and risk factors for loss to follow-up (LTFU) in Korean people living with HIV (PLWH). Materials and Methods: Data from the Korea HIV/AIDS cohort study (including prospective interval cohort and retrospective clinical cohort) were analyzed. LTFU was defined as not visiting the clinic for more than 1 year. Risk factors for LTFU were identified using the Cox regression hazard model. Results: The study enrolled 3,172 adult HIV patients (median age, 36 years; male 92.97%). The median CD4 T cell count at enrollment was 234 cells/mm3 (interquartile range [IQR]: 85 - 373) and the median viral load at enrollment was 56,100 copies/mL (IQR: 15,000 - 203,992). The total follow-up duration was 16,487 person-years, and the overall incidence rate of LTFU was 85/1,000 person-years.In the multivariable Cox regression model, subjects on ART were less likely to have LTFU than subjects not on ART (hazard ratio [HR] = 0.253, 95% confidence interval [CI]: 0.220 - 0.291, P <0.0001). Among PLWH on ART, female sex (HR = 0.752, 95% CI: 0.582 - 0.971, P = 0.0291) and older age (>50: HR = 0.732, 95% CI: 0.602 - 0.890; 41 - 50: HR = 0.634, 95% CI: 0.530 - 0.750; 31 - 40: HR = 0.724, 95% CI: 0.618 - 0.847; ≤30: reference, P <0.0001) were associated with high rate of retention in care. The viral load at ART initiation ≥1,000,001 (HR = 1.545, 95% CI: 1.126 - 2.121, ≤10,000: reference) was associated with a higher rate of LTFU. Conclusion: Young and male PLWH may have a higher rate of LTFU, and an increased rate of LTFU may induce virologic failure.
참고문헌 (16)
- Mberi MN, "Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012 : a cohort study", BMC Health Serv Res, 15, pp.259~ (2015)
- "HIV: fact sheet"[URL]
- The Korean Society for AIDS, "Summary of 2021 Clinical Guidelines for the Diagnosis and Treatment of HIV", AIDS in HIV-infected Koreans, 2021, pp.53(3), 592~616[DOI]
- Cho Yoon-Min, "Assessment of Human Immunodeficiency Virus Care Continuum in Korea using the National Health Insurance System Data", Infection and Chemotherapy, 53(3), pp.477~488 (2021), 대한감염학회[DOI]
- 최보율, "Korea HIV", AIDS Cohort Study: study design and baseline characteristics, 2018, pp.40, 1~8[DOI]
- 김윤정, "Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV", AIDS cohort study, 2006 to 2013, 2016, pp.31(5), 953~960[DOI]
- Shepherd BE, "Impact of definitions of loss to followup on estimates of retention, disease progression, and mortality : application to an HIV program in Mozambique", Am J Epidemiol, 178, pp.819~828 (2013)
- De La Mata NL, "Loss to follow-up trends in HIVpositive patients receiving antiretroviral treatment in Asia from 2003 to 2013", J Acquir Immune Defic Syndr, 74, pp.555~562 (2017)
- Braitstein P, "Mortality of HIV-1-infected patients in the first year of antiretroviral therapy : comparison between low-income and high-income countries", Lancet, 367, pp.817~824 (2006)
- Weigel R, "Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi", BMC Infect Dis, 11, pp.31~ (2011)
- Orrell C, "Virological breakthrough : a risk factor for loss to followup in a large communitybased cohort on antiretroviral therapy", AIDS Res Treat, 2011, pp.469127~ (2011)
- Greig J, "Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa", J Acquir Immune Defic Syndr, 59, pp.e92~8 (2012)
- Nakiwogga-Muwanga A, "Inadequate monitoring in advanced stages of disease with lack of supportive counseling increases attrition among patients on antiretroviral treatment at a large urban clinic in Uganda", J Int Assoc Provid AIDS Care, 13, pp.547~554 (2014)
- Van Cutsem G, "Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa : a cohort analysis", PLoS One, 6, pp.e14684~ (2011)
- Alvarez-Uria G, "Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation : data from an HIV cohort study in India", Glob Health Action, 6, pp.21682~ (2013)
- Clouse K, "Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting", AIDS, 27, pp.645~650 (2013)